These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28623755)

  • 1. Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy.
    Nakhutina L; Kunnakkat SD; Coleman M; Lushbough C; Arnedo V; Soni N; Grant AC
    Epilepsy Behav; 2017 Aug; 73():90-94. PubMed ID: 28623755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
    IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
    Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
    Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
    Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous lacosamide in clinical practice-Results from an independent registry.
    Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
    Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood.
    Gulati P; Cannell P; Ghia T; Bint L; Walsh P; Ghosh S; Nagarajan L
    J Paediatr Child Health; 2015 Aug; 51(8):794-7. PubMed ID: 25683595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Candela C; Mohamed S; Baruzzi A
    Ther Drug Monit; 2013 Dec; 35(6):849-52. PubMed ID: 23942540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
    Kalilani L; Halpern R; Seare J; Dedeken P
    Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wake up to sleep: The effects of lacosamide on daytime sleepiness in adults with epilepsy.
    Foldvary-Schaefer N; Neme-Mercante S; Andrews N; Bruton M; Wang L; Morrison S; Bena J; Grigg-Damberger M
    Epilepsy Behav; 2017 Oct; 75():176-182. PubMed ID: 28866338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
    Markoula S; Teotonio R; Ratnaraj N; Duncan JS; Sander JW; Patsalos PN
    Ther Drug Monit; 2014 Aug; 36(4):494-8. PubMed ID: 24562047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study.
    Borzì G; Di Gennaro G; Schmitt FC; D'Aniello A; Mumoli L; Zummo L; Daniele O; Russo E; Gambardella A; Labate A
    Epilepsy Behav; 2016 May; 58():111-4. PubMed ID: 27064831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs.
    Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J
    Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
    Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
    Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.